The Latest Breaking News from EMA

Nurburgring 24 Hours result upheld after Rowe Racing appeal fails

Rowe Racing's appeal against the result of the Nurburgring 24 Hour race has failed, ensuring Scherer Sport Phx drivers Christopher Mies, Dennis Marschall, Frank Stippler and Ricardo Feller remain victorious.

Autosport · Jul 10, 2024

EU drugs watchdog probes painkiller linked to deaths

Campaigner welcomes investigation into drug after hundreds of suspected adverse reactions

The Guardian - UK · Jun 16, 2024

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

StockNews.com · May 27, 2024

Supercars circuit owner to join WEC field in Manthey Porsche

Shahin and Morris Schuring will pair up with Manthey’s designated Pro driver Richard Lietz at the wheel of the #91 Porsche 911 GT3 R (Type 992) that will be run in collaboration with EMA in the new LMGT3 class.

Autosport · Jan 24, 2024

Wi-Fi’s role in the growing hybrid workforce

Amid a growing remote workforce, IT teams are challenged to provide a smooth Wi-Fi experience.

TechRadar · Jan 17, 2024

Ozempic and Wegovy Show Lower Risk of Suicidal Thoughts

Hold onto your hats, folks, because there's some fascinating news in the world of diabetes and obesity drugs! A recent federal study found that people taki...

Top News · Jan 5, 2024

Autosport Top 50 of 2023: #39 Thomas Preining

Thomas Preining had already marked himself out as a future champion during his rookie DTM season in 2022 with the single-car Team Bernhard operation. So it shouldn’t come as a surprise that he delivered on that promise in his sophomore campaign this year after being given a plum seat at…

Autosport · Dec 21, 2023

Buvidal: is it really a 'game changer' in the treatment of problematic opioid use?

To overcome problematic opioid use, traditional forms of opioid substitution therapy, such as methadone and oral buprenorphine, have become valuable tools. Research shows that patients receiving substitution therapy are more likely to stay in treatment and stop using heroin than patients receiving treatments that do not involve substitutes – such…

The Conversation · Nov 30, 2023

Fears over black market weight loss drugs as people left seriously ill from counterfeit Ozempic

Austria’s criminal investigation service warned on Monday that fake injection pens may still be in circulation

The Independent UK · Oct 24, 2023

3 Promising Pharma Stocks to Keep on Your Radar

The pharma industry’s prospects look bright, thanks to rising demand for generic and innovative drugs and technological advancements. Hence, adding fundamentally strong pharma stocks Astellas Pharma (ALPMY), Sanofi (SNY), and GSK (GSK) to one’s watchlist could be wise. Keep reading.

StockNews.com · Oct 18, 2023